Latest Insider Transactions at Summit Therapeutics Inc. (SMMT)
This section provides a real-time view of insider transactions for Summit Therapeutics Inc. (SMMT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Summit Therapeutics Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Summit Therapeutics Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 03
2024
|
Maky Zanganeh Co-Chief Executive Officer |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
315,681
+3.0%
|
$315,681
$1.58 P/Share
|
|
Sep 11
2024
|
Maky Zanganeh Co-Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
44,052
+0.18%
|
$969,144
$22.7 P/Share
|
|
Sep 11
2024
|
Robert W Duggan Co-Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,325,991
+0.6%
|
$73,171,802
$22.7 P/Share
|
|
Sep 11
2024
|
Jeff Huber Director |
BUY
Grant, award, or other acquisition
|
Indirect |
44,052
+50.0%
|
$969,144
$22.7 P/Share
|
|
Sep 11
2024
|
Bhaskar Anand Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,026
+14.35%
|
$484,572
$22.7 P/Share
|
|
Sep 11
2024
|
Manmeet Singh Soni COO and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
44,052
+1.44%
|
$969,144
$22.7 P/Share
|
|
Mar 27
2024
|
Maky Zanganeh Co-Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
54,321
+14.35%
|
$162,963
$3.72 P/Share
|
|
Mar 27
2024
|
Maky Zanganeh Co-Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
26,000
+4.75%
|
$78,000
$3.72 P/Share
|
|
Mar 26
2024
|
Ankur Dhingra Chief Financial Officer |
BUY
Open market or private purchase
|
Indirect |
100,000
+21.98%
|
$300,000
$3.75 P/Share
|
|
Mar 26
2024
|
Maky Zanganeh Co-Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
30,000
+50.0%
|
$90,000
$3.75 P/Share
|
|
Dec 13
2023
|
Ankur Dhingra Chief Financial Officer |
BUY
Open market or private purchase
|
Indirect |
20,400
+3.73%
|
$40,800
$2.16 P/Share
|
|
Dec 12
2023
|
Maky Zanganeh Co-Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+1.0%
|
$10,000
$2.07 P/Share
|
|
Dec 11
2023
|
Maky Zanganeh Co-Chief Executive Officer |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
315,681
+1.25%
|
$315,681
$1.58 P/Share
|
|
Dec 11
2023
|
Maky Zanganeh Co-Chief Executive Officer |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
489,814
+50.0%
|
$489,814
$1.44 P/Share
|
|
Oct 13
2023
|
Manmeet Singh Soni COO and CFO |
BUY
Open market or private purchase
|
Direct |
2,976,190
+50.0%
|
$2,976,190
$1.68 P/Share
|
|
Mar 08
2023
|
Maky Zanganeh Co-Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
7,553,301
+40.57%
|
$7,553,301
$1.05 P/Share
|
|
Mar 08
2023
|
Maky Zanganeh Co-Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
15,973,743
+40.57%
|
$15,973,743
$1.05 P/Share
|
|
Mar 07
2023
|
Ankur Dhingra Chief Financial Officer |
BUY
Open market or private purchase
|
Indirect |
196,362
+45.57%
|
$196,362
$1.05 P/Share
|
|
Mar 06
2023
|
Robert W Duggan Co-Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
376,489,880
+40.53%
|
$376,489,880
$1.05 P/Share
|
|
Dec 06
2022
|
Maky Zanganeh Co-Chief Executive Officer |
BUY
Other acquisition or disposition
|
Direct |
373,857
+3.31%
|
-
|
|
Dec 06
2022
|
Robert W Duggan Co-Chief Executive Officer |
BUY
Other acquisition or disposition
|
Direct |
9,346,434
+5.16%
|
-
|
|
Aug 16
2022
|
Maky Zanganeh Co-Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
5,624,702
+32.08%
|
$0
$0.97 P/Share
|
|
Aug 16
2022
|
Maky Zanganeh Co-Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
184,430
+33.88%
|
$0
$0.97 P/Share
|
|
Aug 16
2022
|
Robert W Duggan Co-Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
94,849,203
+36.85%
|
$0
$0.97 P/Share
|
|
Aug 16
2022
|
Ankur Dhingra Chief Financial Officer |
BUY
Open market or private purchase
|
Indirect |
24,658
+39.23%
|
$0
$0.97 P/Share
|
|
Aug 16
2022
|
Ankur Dhingra Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
11,557
+23.29%
|
$0
$0.97 P/Share
|
|
May 23
2022
|
Robert W Duggan Co-Chief Executive Officer |
BUY
Other acquisition or disposition
|
Direct |
21,135
+0.03%
|
-
|
|
May 12
2021
|
Maky Zanganeh Co-Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
389,077
+12.83%
|
$1,945,385
$5.24 P/Share
|
|
May 12
2021
|
Robert W Duggan Co-Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
11,365,921
+14.38%
|
$56,829,605
$5.24 P/Share
|
|
Nov 30
2020
|
David Jonathan Powell Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
13,713
-100.0%
|
$54,852
$4.44 P/Share
|
|
Nov 30
2020
|
David Jonathan Powell Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,713
+50.0%
|
$13,713
$1.79 P/Share
|
|
Nov 27
2020
|
David Jonathan Powell Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
29,569
-100.0%
|
$118,276
$4.39 P/Share
|
|
Nov 27
2020
|
David Jonathan Powell Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
29,569
+40.23%
|
$29,569
$1.86 P/Share
|
|
Nov 25
2020
|
David Jonathan Powell Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
12,070
-100.0%
|
$48,280
$4.32 P/Share
|
|
Nov 25
2020
|
David Jonathan Powell Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,070
+50.0%
|
$12,070
$1.92 P/Share
|
|
Nov 24
2020
|
David Jonathan Powell Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
11,374
-100.0%
|
$45,496
$4.21 P/Share
|
|
Nov 24
2020
|
David Jonathan Powell Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,374
+50.0%
|
$11,374
$1.92 P/Share
|
|
Nov 23
2020
|
David Jonathan Powell Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
6,987
-100.0%
|
$27,948
$4.4 P/Share
|
|
Nov 23
2020
|
David Jonathan Powell Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,987
+50.0%
|
$6,987
$1.92 P/Share
|
|
Nov 06
2020
|
Robert W Duggan Co-Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
14,071,856
+20.0%
|
$42,215,568
$3.34 P/Share
|